Last Updated: 08/06/2026

SYMBIOTIC.BLUE

London

Founded 2025

Brain-inspired AI platform for multi-target drug discovery

Symbiotic.blue is a pre-seed biotech company developing an AI-driven drug discovery platform that combines generative AI with neuroscience-inspired computational methods.

The platform aims to design molecules capable of acting on multiple biological targets simultaneously, with an initial focus on obesity.

The company was founded by academics from the Universities of Oxford and Cambridge alongside life sciences industry veterans.

Biotech AI & Machine Learning Drug Discovery

Metabolic Disease

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page

Similar Companies